$300,000.00 SETTLEMENT
Our client was prescribed Elmiron, a medication containing the active ingredient pentosan polysulfate, to treat bladder pain and discomfort associated with interstitial cystitis. Medical research has since shown that this chemical is strongly linked to a serious, vision-threatening condition known as macular disease. After taking Elmiron, our client began to suffer significant vision loss. It was later revealed that the manufacturer had failed to provide adequate warnings that vision damage was a potential side effect of the drug. With the guidance of the experienced product liability team at Charles Boyk Law Offices, our client successfully pursued litigation and obtained compensation for her injuries.
